These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23527719)
21. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis. Peixoto Lira RC; Fedatto PF; Marco Antonio DS; Leal LF; Martinelli CE; de Castro M; Tucci S; Neder L; Ramalho L; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Rauber Antonini SR; Scrideli CA Endocr Relat Cancer; 2016 Jun; 23(6):481-93. PubMed ID: 27185872 [TBL] [Abstract][Full Text] [Related]
22. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [TBL] [Abstract][Full Text] [Related]
23. Protein intake during gestation affects postnatal bovine skeletal muscle growth and relative expression of IGF1, IGF1R, IGF2 and IGF2R. Micke GC; Sullivan TM; McMillen IC; Gentili S; Perry VE Mol Cell Endocrinol; 2011 Jan; 332(1-2):234-41. PubMed ID: 21056085 [TBL] [Abstract][Full Text] [Related]
24. Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation. Vella V; Nicolosi ML; Giuliano M; Morrione A; Malaguarnera R; Belfiore A Cells; 2019 Sep; 8(9):. PubMed ID: 31480557 [TBL] [Abstract][Full Text] [Related]
26. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas. de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor 2 and its enterocyte receptor are not required for adaptation in response to massive small bowel resection. Sun RC; Choi PM; Guo J; Erwin CR; Warner BW J Pediatr Surg; 2014 Jun; 49(6):966-70; discussion 970. PubMed ID: 24888844 [TBL] [Abstract][Full Text] [Related]
28. Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation. Deitel K; Dantzer D; Ferguson P; Pollak M; Beamer W; Andrulis I; Bell R J Surg Oncol; 2002 Oct; 81(2):75-9. PubMed ID: 12355407 [TBL] [Abstract][Full Text] [Related]
29. IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. Huang X; Park H; Greene J; Pao J; Mulvey E; Zhou SX; Albert CM; Moy F; Sachdev D; Yee D; Rader C; Hamby CV; Loeb DM; Cairo MS; Zhou X PLoS One; 2015; 10(7):e0133152. PubMed ID: 26173023 [TBL] [Abstract][Full Text] [Related]
30. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910 [TBL] [Abstract][Full Text] [Related]
31. IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis. Dallinga MG; Habani YI; Kayser RP; Van Noorden CJF; Klaassen I; Schlingemann RO Mol Biol Rep; 2020 Apr; 47(4):2561-2572. PubMed ID: 32133604 [TBL] [Abstract][Full Text] [Related]
32. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738 [TBL] [Abstract][Full Text] [Related]
33. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade. Iams WT; Lovly CM Clin Cancer Res; 2015 Oct; 21(19):4270-7. PubMed ID: 26429980 [TBL] [Abstract][Full Text] [Related]
34. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511 [TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor system on adrenocortical tumorigenesis. Ribeiro TC; Latronico AC Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903 [TBL] [Abstract][Full Text] [Related]
36. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors. Andersson MK; Åman P; Stenman G Cells; 2019 Aug; 8(8):. PubMed ID: 31426421 [TBL] [Abstract][Full Text] [Related]
37. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation. Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974 [TBL] [Abstract][Full Text] [Related]
38. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors. Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396 [TBL] [Abstract][Full Text] [Related]
39. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6. Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422 [TBL] [Abstract][Full Text] [Related]
40. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Ye B; Jiang LL; Xu HT; Zhou DW; Li ZS Int J Immunopathol Pharmacol; 2012; 25(3):627-36. PubMed ID: 23058013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]